↓ Skip to main content

Dove Medical Press

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes

Overview of attention for article published in Drug Design, Development and Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
285 Dimensions

Readers on

mendeley
312 Mendeley
Title
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
Published in
Drug Design, Development and Therapy, September 2014
DOI 10.2147/dddt.s50773
Pubmed ID
Authors

Michael A Nauck

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 312 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Unknown 310 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 43 14%
Student > Ph. D. Student 31 10%
Researcher 31 10%
Student > Master 31 10%
Student > Postgraduate 25 8%
Other 62 20%
Unknown 89 29%
Readers by discipline Count As %
Medicine and Dentistry 102 33%
Pharmacology, Toxicology and Pharmaceutical Science 39 13%
Biochemistry, Genetics and Molecular Biology 22 7%
Agricultural and Biological Sciences 15 5%
Chemistry 11 4%
Other 26 8%
Unknown 97 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2022.
All research outputs
#8,616,072
of 25,576,801 outputs
Outputs from Drug Design, Development and Therapy
#646
of 2,254 outputs
Outputs of similar age
#82,390
of 249,031 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 49 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,031 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.